Search research articles
Contact Us
Filters
Showing results (11-20 of 117) with videos related to
Page
of 12
Sort By:
Sportverletzung Sportschaden : Organ Der Gesellschaft Fur Orthopadisch-Traumatologische Sportmedizin
|
March 16, 2010
[Diagnostic tools for endurance testing in handball players]
R Schwesig, H Weirauch, P Eder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1989
Bone marrow autotransplantation for solid tumors--prospects
E Frei, K Antman, B Teicher, et al.
The Journal of Biological Chemistry
|
January 25, 1993
Molecular cloning and identification of a point mutation in the topoisomerase II cDNA from an etoposide-resistant Chinese hamster ovary cell line
V T Chan, S W Ng, J P Eder, et al.
Cancer Research
|
January 15, 1991
A phase I clinical trial of novobiocin, a modulator of alkylating agent cytotoxicity
J P Eder, C A Wheeler, B A Teicher, et al.
The Journal of Biological Chemistry
|
October 27, 1995
Molecular cloning and characterization of the promoter for the Chinese hamster DNA topoisomerase II alpha gene
S W Ng, J P Eder, L E Schnipper, et al.
JAAD Case Reports
|
December 28, 2020
Skin puckering and edema during durvalumab therapy
Brianna Olamiju, Ian Odell, Gauri Panse, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 3, 2005
Safety and pharmacokinetics of the dual action Raf kinase and vascular endothelial growth factor receptor inhibitor, BAY 43-9006, in patients with advanced, refractory solid tumors
Jeffrey W Clark, Joseph P Eder, David Ryan, et al.
Acta Gastro-Enterologica Belgica
|
May 9, 2013
Ventricular tachyarrhythmia after adalimumab therapy in a patient with Crohn's disease
P Eder, L Lykowska-Szuber, I Krela-Kazmierczak, et al.
The Journal of Biological Chemistry
|
July 5, 1993
Conditional expression of wild-type topoisomerase II complements a mutant enzyme in mammalian cells
J P Eder, V T Chan, E Niemierko, et al.
Leukemia
|
January 1, 1997
Cyclic AMP negatively controls c-myc transcription and G1 cell cycle progression in p210 BCR-ABL transformed cells: inhibitory activity exerted through cyclin D1 and cdk4
E A Williamson, G S Burgess, P Eder, et al.
Page
of 12
Search research articles
Search
Showing results (11-20 of 117) with videos related to
Sort By:
Page
of 12
Sportverletzung Sportschaden : Organ Der Gesellschaft Fur Orthopadisch-Traumatologische Sportmedizin
|
March 16, 2010
[Diagnostic tools for endurance testing in handball players]
R Schwesig, H Weirauch, P Eder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1989
Bone marrow autotransplantation for solid tumors--prospects
E Frei, K Antman, B Teicher, et al.
The Journal of Biological Chemistry
|
January 25, 1993
Molecular cloning and identification of a point mutation in the topoisomerase II cDNA from an etoposide-resistant Chinese hamster ovary cell line
V T Chan, S W Ng, J P Eder, et al.
Cancer Research
|
January 15, 1991
A phase I clinical trial of novobiocin, a modulator of alkylating agent cytotoxicity
J P Eder, C A Wheeler, B A Teicher, et al.
The Journal of Biological Chemistry
|
October 27, 1995
Molecular cloning and characterization of the promoter for the Chinese hamster DNA topoisomerase II alpha gene
S W Ng, J P Eder, L E Schnipper, et al.
JAAD Case Reports
|
December 28, 2020
Skin puckering and edema during durvalumab therapy
Brianna Olamiju, Ian Odell, Gauri Panse, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 3, 2005
Safety and pharmacokinetics of the dual action Raf kinase and vascular endothelial growth factor receptor inhibitor, BAY 43-9006, in patients with advanced, refractory solid tumors
Jeffrey W Clark, Joseph P Eder, David Ryan, et al.
Acta Gastro-Enterologica Belgica
|
May 9, 2013
Ventricular tachyarrhythmia after adalimumab therapy in a patient with Crohn's disease
P Eder, L Lykowska-Szuber, I Krela-Kazmierczak, et al.
The Journal of Biological Chemistry
|
July 5, 1993
Conditional expression of wild-type topoisomerase II complements a mutant enzyme in mammalian cells
J P Eder, V T Chan, E Niemierko, et al.
Leukemia
|
January 1, 1997
Cyclic AMP negatively controls c-myc transcription and G1 cell cycle progression in p210 BCR-ABL transformed cells: inhibitory activity exerted through cyclin D1 and cdk4
E A Williamson, G S Burgess, P Eder, et al.
Page
of 12